TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) currently has a daily average trading volume of 112.68K but it saw 6568465 shares traded in last market. With a market cap of 0.07M USD, the company’s current market price of $2.46 came falling about -28.07 while comparing to the previous closing price of $3.42. In past 52 weeks, the stock remained buoying in the range of price level as high as $523.20 and as low as $3.18. In the recent trading on the day, stock has struck highest price mark of $2.27 while lowest mark touched by it was $3.61.
Taking a look at 20-day trading activity of TC BioPharm (Holdings) plc ADR (TCBP) gives us an average price of $5.73, while its current price level is -99.53% below from 52-week high level whereas it is -22.64% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $7.98 while that of 200 days or SMA-200 reads an average of $81.66. A closer look into the stock’s movement over the week reveals that its volatility is standing at 27.96% during that period while stretching the period over a month that decreases to 23.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.23 which implies that the stock is in oversold territory.
Over the week, TCBP’s stock price is moving -47.15% down while it is -73.25% when we observe its performance for the past one month. Year-to-date it is -76.16% down and over the past year, the stock is showing a downside performance of -98.59%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, TC BioPharm (Holdings) plc ADR’s total number of outstanding shares is 0.03M with 0.01% of that held by the insiders while 7.01% of its common stock has been owned by the institutions. Stock’s beta reads -0.11. Stock has a price to book (P/B) ratio of 1.24.
